Pacemakers, implantable cardiac defibrillators, and cardiac resynchronization therapy devices are potentially life-saving treatments for a number of cardiac conditions, but are not without risk. Most concerning is the risk of a cardiac implantable electronic device (CIED) infection, which is associated with significant morbidity, increased hospitalizations, reduced survival, and increased healthcare costs. Recommended preventive strategies such as administration of intravenous antibiotics before implantation are well recognized. Uncertainties have remained about the role of various preventive, diagnostic, and treatment measures such as skin antiseptics, pocket antibiotic solutions, anti-bacterial envelopes, prolonged antibiotics post-implantation, and others. Guidance on whether to use novel device alternatives expected to be less prone to infections and novel oral anticoagulants is also limited, as are definitions on minimum quality requirements for centres and operators and volumes. Moreover, an international consensus document on management of CIED infections is lacking. The recognition of these issues, the dissemination of results from important randomized trials focusing on prevention of CIED infections, and observed divergences in managing device-related infections as found in an European Heart Rhythm Association worldwide survey, provided a strong incentive for a 2019 International State-of-the-art Consensus document on risk assessment, prevention, diagnosis, and treatment of CIED infections.

European Heart Rhythm Association (EHRA) international consensus document on how to prevent, diagnose, and treat cardiac implantable electronic device infections - Endorsed by the Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society (APHRS), the Latin American Heart Rhythm Society (LAHRS), International Society for Cardiovascular Infectious Diseases (ISCVID) and the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS) / Blomstrom-Lundqvist, C.; Traykov, V.; Erba, P. A.; Burri, H.; Nielsen, J. C.; Bongiorni, M. G.; Poole, J.; Boriani, G.; Costa, R.; Deharo, J. -C.; Epstein, L. M.; Saghy, L.; Snygg-Martin, U.; Starck, C.; Tascini, C.; Strathmore, N.; Kalarus, Z.; Boveda, S.; Dagres, N.; Rinaldi, C. A.; Biffi, M.; Geller, L.; Sokal, A.; Birgersdotter-Green, U.; Lever, N.; Tajstra, M.; Kutarski, A.; Rodriguez, D. A.; Hasse, B.; Zinkernagel, A.; Mangoni, E.. - In: EUROPACE. - ISSN 1099-5129. - 22:4(2020), pp. 515-549. [10.1093/europace/euz246]

European Heart Rhythm Association (EHRA) international consensus document on how to prevent, diagnose, and treat cardiac implantable electronic device infections - Endorsed by the Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society (APHRS), the Latin American Heart Rhythm Society (LAHRS), International Society for Cardiovascular Infectious Diseases (ISCVID) and the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)

Boriani G.;
2020

Abstract

Pacemakers, implantable cardiac defibrillators, and cardiac resynchronization therapy devices are potentially life-saving treatments for a number of cardiac conditions, but are not without risk. Most concerning is the risk of a cardiac implantable electronic device (CIED) infection, which is associated with significant morbidity, increased hospitalizations, reduced survival, and increased healthcare costs. Recommended preventive strategies such as administration of intravenous antibiotics before implantation are well recognized. Uncertainties have remained about the role of various preventive, diagnostic, and treatment measures such as skin antiseptics, pocket antibiotic solutions, anti-bacterial envelopes, prolonged antibiotics post-implantation, and others. Guidance on whether to use novel device alternatives expected to be less prone to infections and novel oral anticoagulants is also limited, as are definitions on minimum quality requirements for centres and operators and volumes. Moreover, an international consensus document on management of CIED infections is lacking. The recognition of these issues, the dissemination of results from important randomized trials focusing on prevention of CIED infections, and observed divergences in managing device-related infections as found in an European Heart Rhythm Association worldwide survey, provided a strong incentive for a 2019 International State-of-the-art Consensus document on risk assessment, prevention, diagnosis, and treatment of CIED infections.
2020
22
4
515
549
European Heart Rhythm Association (EHRA) international consensus document on how to prevent, diagnose, and treat cardiac implantable electronic device infections - Endorsed by the Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society (APHRS), the Latin American Heart Rhythm Society (LAHRS), International Society for Cardiovascular Infectious Diseases (ISCVID) and the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS) / Blomstrom-Lundqvist, C.; Traykov, V.; Erba, P. A.; Burri, H.; Nielsen, J. C.; Bongiorni, M. G.; Poole, J.; Boriani, G.; Costa, R.; Deharo, J. -C.; Epstein, L. M.; Saghy, L.; Snygg-Martin, U.; Starck, C.; Tascini, C.; Strathmore, N.; Kalarus, Z.; Boveda, S.; Dagres, N.; Rinaldi, C. A.; Biffi, M.; Geller, L.; Sokal, A.; Birgersdotter-Green, U.; Lever, N.; Tajstra, M.; Kutarski, A.; Rodriguez, D. A.; Hasse, B.; Zinkernagel, A.; Mangoni, E.. - In: EUROPACE. - ISSN 1099-5129. - 22:4(2020), pp. 515-549. [10.1093/europace/euz246]
Blomstrom-Lundqvist, C.; Traykov, V.; Erba, P. A.; Burri, H.; Nielsen, J. C.; Bongiorni, M. G.; Poole, J.; Boriani, G.; Costa, R.; Deharo, J. -C.; Epstein, L. M.; Saghy, L.; Snygg-Martin, U.; Starck, C.; Tascini, C.; Strathmore, N.; Kalarus, Z.; Boveda, S.; Dagres, N.; Rinaldi, C. A.; Biffi, M.; Geller, L.; Sokal, A.; Birgersdotter-Green, U.; Lever, N.; Tajstra, M.; Kutarski, A.; Rodriguez, D. A.; Hasse, B.; Zinkernagel, A.; Mangoni, E.
File in questo prodotto:
File Dimensione Formato  
euz246.pdf

Open access

Tipologia: Versione pubblicata dall'editore
Dimensione 2.2 MB
Formato Adobe PDF
2.2 MB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/1227116
Citazioni
  • ???jsp.display-item.citation.pmc??? 63
  • Scopus 220
  • ???jsp.display-item.citation.isi??? 197
social impact